prepopik Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4473 None

Description:

MoleculeDescription

Synonyms:

  • prepopik
  • sodium picosulfate, magnesium oxide and citric acid
  • Molecular weight: 713.83
  • Formula: C24H21MgNNa2O16S2
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 145.75
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
July 16, 2012 FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

None

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Colonoscopy indication 73761001

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRouteExclusivity dateDescription
12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** PREPOPIK FERRING PHARMS INC N202535 July 16, 2012 DISCN FOR SOLUTION ORAL Aug. 15, 2021 NEW PATIENT POPULATION

Bioactivity Summary:

None

External reference:

IDSource
C3485036 UMLSCUI
118988661 PUBCHEM_CID
1304095 RXNORM
192137 MMSL

Pharmaceutical products:

None